EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
CVS sues to overturn Tennessee PBM law
The legal action challenges the statute's constitutionality.
Memorial Day office closure
Regular business operations will resume on Tuesday, May 26.
Datascan’s Minassian on evolving independent pharmacy technology
Why it’s important to find pharmacy management software that works for you.
TPA and NCPA praise Tennessee law banning PBMs from owning pharmacies
“Today marks a historic step forward for patients and pharmacists across Tennessee,” said Anthony Pudlo, CEO of the Tennessee Pharmacists Association.